RemeGen Revenue

In the year 2025, RemeGen had annual revenue of 3.25B CNY with 89.36% growth. RemeGen had revenue of 1.53B in the quarter ending December 31, 2025, with 201.43% growth.

Revenue

3.25B CNY

Revenue Growth

+89.36%

P/S Ratio

16.69

Revenue / Employee

1.06M CNY

Employees

3,070

Market Cap

60.37B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.25B	1.53B	89.36%
Dec 31, 2024	1.72B	633.91M	58.54%
Dec 31, 2023	1.08B	310.84M	40.26%
Dec 31, 2022	772.11M	-651.79M	-45.78%
Dec 31, 2021	1.42B	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
3SBio	9.94B
Sichuan Kelun-Biotech Biopharmaceutical	1.64B
Shanghai Henlius Biotech	6.35B
Akeso	2.75B
Biocytogen Pharmaceuticals (Beijing)	1.53B
Sino Biopharmaceutical	33.49B
Shanghai Junshi Biosciences	2.78B
Duality Biotherapeutics	2.38B

Revenue Rankings